Enzolytics Inc (ENZC)

[Valuator2]

FWIW...from today's PR:
https://finance.yahoo.com/news/sagaliam-acquisition-corp-announces-novation-120000626.html
Apparently, BGEN still has all its IP and assets:

Under this restructured agreement SAGA retains 100% ownership of VIRO, ITV-1, the nutraceutical products and license along with VIRO's other assets. This agreement transferred ownership of Biogenysis, Inc. ("BGEN") and it's IP, patents and associated asset being developed back to ENZC in exchange for a reduction of the price from $450,000,000 to $290,000,000 with the dividend of the purchase shares to come directly to the ENZC shareholders from SAGA.

IMO, the preference of 9 million SAGA shares to management should be adjusted prorata as well, if not eliminated altogether. This as well as the double dipping into the dividend calculation/share with conversion of Series B's is what piss*d off most of us. Fixing this could go a long way toward regaining confidence among shareholders and heading off the potential for associated litigation.

All other terms and conditions of the purchase agreement, including the make-whole provision relating to the 29 million SAGA shares, remain in place.